Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia ...
Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for the prevention of invasive disease and pneumonia caused …